The National Association for the Advancement of Orthotics and Prosthetics (“NAAOP”), commends the U.S. Department of Health and Human Services (“HHS”) and the Centers for Medicare and Medicaid Services (“CMS”) for announcing today the expansion of Medicare and Medicaid coverage for anti-obesity medications to treat obesity itself, effective in January 2026. Due to the significant impact that obesity and related chronic conditions such as diabetes and cardio-vascular disease h
